Works matching IS 0008543X AND DT 2024 AND VI 130 AND IP 1


Results: 21
    1
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Efficacy and safety of tixagevimab‐cilgavimab versus SARS‐CoV‐2 breakthrough infection in the hematological conditions.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 1, p. 41, doi. 10.1002/cncr.35005
    By:
    • Duminuco, Andrea;
    • Nardo, Antonella;
    • Orofino, Alessandra;
    • Giunta, Giuliana;
    • Conticello, Concetta;
    • Del Fabro, Vittorio;
    • Chiarenza, Annalisa;
    • Parisi, Marina S.;
    • Figuera, Amalia;
    • Leotta, Salvatore;
    • Milone, Giuseppe;
    • Cupri, Alessandra;
    • Cambria, Daniela;
    • Di Raimondo, Francesco;
    • Romano, Alessandra;
    • Palumbo, Giuseppe A.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Issue Information.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 1, p. 1, doi. 10.1002/cncr.34278
    Publication type:
    Article